Annual Operating Profit
-$225.97 M
+$383.71 M+62.94%
December 31, 2024
Summary
- As of March 10, 2025, SMMT annual operating income is -$225.97 million, with the most recent change of +$383.71 million (+62.94%) on December 31, 2024.
- During the last 3 years, SMMT annual operating profit has fallen by -$139.80 million (-162.22%).
- SMMT annual operating profit is now -2367.87% below its all-time high of $9.96 million, reached on January 31, 2019.
Performance
SMMT Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$80.59 M
-$22.22 M-38.06%
December 31, 2024
Summary
- As of March 10, 2025, SMMT quarterly operating income is -$80.59 million, with the most recent change of -$22.22 million (-38.06%) on December 31, 2024.
- Over the past year, SMMT quarterly operating profit has stayed the same.
- SMMT quarterly operating profit is now -315.48% below its all-time high of $37.40 million, reached on July 31, 2018.
Performance
SMMT Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$225.97 M
+$476.57 M+67.84%
December 31, 2024
Summary
- As of March 10, 2025, SMMT TTM operating income is -$225.97 million, with the most recent change of +$476.57 million (+67.84%) on December 31, 2024.
- Over the past year, SMMT TTM operating profit has stayed the same.
- SMMT TTM operating profit is now -1794.44% below its all-time high of $13.34 million, reached on April 1, 2019.
Performance
SMMT TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
SMMT Operating Profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +62.9% | 0.0% | 0.0% |
3 y3 years | -162.2% | 0.0% | 0.0% |
5 y5 years | -722.5% | 0.0% | 0.0% |
SMMT Operating Profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -236.9% | +62.9% | -581.2% | +85.5% | -291.6% | +67.8% |
5 y | 5-year | -722.5% | +62.9% | -762.9% | +85.5% | -744.5% | +67.8% |
alltime | all time | -2367.9% | +62.9% | -315.5% | +85.5% | -1794.4% | +67.8% |
Summit Therapeutics Operating Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | -$225.97 M(-62.9%) | -$80.59 M(+38.1%) | -$225.97 M(-67.8%) |
Sep 2024 | - | -$58.38 M(+30.9%) | -$702.54 M(+5.7%) |
Jun 2024 | - | -$44.61 M(+5.2%) | -$664.65 M(+4.5%) |
Mar 2024 | - | -$42.39 M(-92.4%) | -$635.84 M(+4.3%) |
Dec 2023 | -$609.68 M(+808.9%) | -$557.16 M(+2618.9%) | -$609.68 M(+847.4%) |
Sep 2023 | - | -$20.49 M(+29.7%) | -$64.36 M(+5.8%) |
Jun 2023 | - | -$15.79 M(-2.7%) | -$60.80 M(+5.4%) |
Mar 2023 | - | -$16.24 M(+37.3%) | -$57.70 M(-9.3%) |
Dec 2022 | -$67.08 M(-22.2%) | -$11.83 M(-30.2%) | -$63.62 M(-18.3%) |
Sep 2022 | - | -$16.94 M(+33.5%) | -$77.83 M(-3.2%) |
Jun 2022 | - | -$12.69 M(-42.7%) | -$80.37 M(-12.1%) |
Mar 2022 | - | -$22.16 M(-14.9%) | -$91.41 M(+6.1%) |
Dec 2021 | -$86.17 M(+64.8%) | -$26.04 M(+33.6%) | -$86.17 M(+20.3%) |
Sep 2021 | - | -$19.49 M(-17.9%) | -$71.66 M(+5.0%) |
Jun 2021 | - | -$23.73 M(+40.2%) | -$68.26 M(+14.0%) |
Mar 2021 | - | -$16.92 M(+46.9%) | -$59.88 M(+14.5%) |
Dec 2020 | -$52.30 M(+90.4%) | - | - |
Dec 2020 | - | -$11.52 M(-28.3%) | -$52.30 M(+28.3%) |
Sep 2020 | - | -$16.08 M(+4.7%) | -$40.78 M(+17.8%) |
Jun 2020 | - | -$15.36 M(+64.4%) | -$34.62 M(+29.4%) |
Mar 2020 | - | -$9.34 M(-5.9%) | -$26.76 M(-9.6%) |
Dec 2019 | -$27.47 M(-375.7%) | - | - |
Oct 2019 | - | -$9.93 M(+32.5%) | -$29.60 M(-6.2%) |
Jul 2019 | - | -$7.49 M(+20.5%) | -$31.56 M(-336.6%) |
Apr 2019 | - | -$6.22 M(+4.2%) | $13.34 M(+27.2%) |
Jan 2019 | $9.96 M(-129.6%) | - | - |
Jan 2019 | - | -$5.97 M(-49.8%) | $10.48 M(+255.3%) |
Oct 2018 | - | -$11.88 M(-131.8%) | $2.95 M(-63.0%) |
Jul 2018 | - | $37.40 M(-512.3%) | $7.96 M(-122.7%) |
Apr 2018 | - | -$9.07 M(-32.8%) | -$35.15 M(+4.9%) |
Jan 2018 | -$33.69 M | - | - |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jan 2018 | - | -$13.50 M(+96.6%) | -$33.50 M(+21.9%) |
Oct 2017 | - | -$6.87 M(+20.2%) | -$27.49 M(+1.5%) |
Jul 2017 | - | -$5.71 M(-23.1%) | -$27.08 M(-12.7%) |
Apr 2017 | - | -$7.42 M(-0.9%) | -$31.01 M(-4.9%) |
Jan 2017 | -$30.40 M(+4.9%) | - | - |
Jan 2017 | - | -$7.49 M(+16.0%) | -$32.61 M(+1.2%) |
Oct 2016 | - | -$6.45 M(-33.1%) | -$32.22 M(-5.8%) |
Jul 2016 | - | -$9.64 M(+6.8%) | -$34.22 M(+6.7%) |
Apr 2016 | - | -$9.03 M(+27.2%) | -$32.07 M(+11.0%) |
Jan 2016 | -$28.98 M(+57.2%) | - | - |
Jan 2016 | - | -$7.10 M(-16.0%) | -$28.90 M(+13.1%) |
Oct 2015 | - | -$8.45 M(+12.9%) | -$25.56 M(+18.6%) |
Jul 2015 | - | -$7.49 M(+27.7%) | -$21.55 M(+7.2%) |
Apr 2015 | - | -$5.86 M(+55.9%) | -$20.11 M(+5.9%) |
Jan 2015 | -$18.43 M(+66.6%) | - | - |
Jan 2015 | - | -$3.76 M(-15.3%) | -$18.99 M(-2.1%) |
Oct 2014 | - | -$4.44 M(-26.6%) | -$19.40 M(+6.5%) |
Jul 2014 | - | -$6.05 M(+27.5%) | -$18.22 M(+49.7%) |
Apr 2014 | - | -$4.74 M(+13.7%) | -$12.17 M(+63.8%) |
Jan 2014 | -$11.07 M(+53.2%) | - | - |
Jan 2014 | - | -$4.17 M(+28.0%) | -$7.43 M(+128.0%) |
Oct 2013 | - | -$3.26 M | -$3.26 M |
Jan 2013 | -$7.22 M(+53.2%) | - | - |
Jan 2012 | -$4.71 M(-190.8%) | - | - |
Jan 2011 | $5.19 M(-146.9%) | - | - |
Jan 2010 | -$11.06 M(-26.8%) | - | - |
Jan 2009 | -$15.11 M(-33.0%) | - | - |
Jan 2008 | -$22.55 M(+162.3%) | - | - |
Jan 2007 | -$8.60 M(+167.5%) | - | - |
Jan 2006 | -$3.21 M(+498.8%) | - | - |
Jan 2005 | -$536.60 K | - | - |
FAQ
- What is Summit Therapeutics annual operating income?
- What is the all time high annual operating profit for Summit Therapeutics?
- What is Summit Therapeutics annual operating profit year-on-year change?
- What is Summit Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Summit Therapeutics?
- What is Summit Therapeutics quarterly operating profit year-on-year change?
- What is Summit Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Summit Therapeutics?
- What is Summit Therapeutics TTM operating profit year-on-year change?
What is Summit Therapeutics annual operating income?
The current annual operating profit of SMMT is -$225.97 M
What is the all time high annual operating profit for Summit Therapeutics?
Summit Therapeutics all-time high annual operating income is $9.96 M
What is Summit Therapeutics annual operating profit year-on-year change?
Over the past year, SMMT annual operating income has changed by +$383.71 M (+62.94%)
What is Summit Therapeutics quarterly operating income?
The current quarterly operating profit of SMMT is -$80.59 M
What is the all time high quarterly operating profit for Summit Therapeutics?
Summit Therapeutics all-time high quarterly operating income is $37.40 M
What is Summit Therapeutics quarterly operating profit year-on-year change?
Over the past year, SMMT quarterly operating income has changed by $0.00 (0.00%)
What is Summit Therapeutics TTM operating income?
The current TTM operating profit of SMMT is -$225.97 M
What is the all time high TTM operating profit for Summit Therapeutics?
Summit Therapeutics all-time high TTM operating income is $13.34 M
What is Summit Therapeutics TTM operating profit year-on-year change?
Over the past year, SMMT TTM operating income has changed by $0.00 (0.00%)